CLIENT NEWS
Molecular Health licenses its proprietary predictive analytics to DATEN CAPITAL
07 January 2019
Biom’up: Achievement of two major development milestones
07 January 2019
Rentschler Biopharma completes acquisition of U.S. manufacturing site
03 January 2019
InflaRx continues U.S. expansion with addition of New York City corporate office and addition of management
03 January 2019
Verona Pharma appoints Kathleen Rickard, MD, as chief medical officer to lead late stage clinical development of RPL554
03 January 2019
Atriva Therapeutics announces first closing of series A financing round
03 January 2019
Molecular Health licenses its proprietary predictive analytics to DATEN CAPITAL07 January 2019
Biom’up: Achievement of two major development milestones07 January 2019
Rentschler Biopharma completes acquisition of U.S. manufacturing site03 January 2019
InflaRx continues U.S. expansion with addition of New York City corporate office and addition of management03 January 2019
Verona Pharma appoints Kathleen Rickard, MD, as chief medical officer to lead late stage clinical development of RPL55403 January 2019
Atriva Therapeutics announces first closing of series A financing round03 January 2019